Cell sources for bioartificial liver support

International Journal of Artificial Organs

Volumn 19, Issue 1, 1996, Pages 14-17

  Stange, J ^a   Mitzner, S ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Bioartificial liver support; Detoxification; Hepatic failure; Hepatocyte culture; Liver cell lines; Primary hepatocytes

Indexed keywords

ARTIFICIAL ORGANS; BIOSYNTHESIS; CELLS; DETOXIFICATION;

BIOARTIFICIAL LIVER; BIOARTIFICIAL LIVER SUPPORT; CELL LINES; CELL SOURCES; HEPATIC FAILURE; HEPATOCYTE CULTURE; HEPATOCYTES; LIVER CELLS; LIVER-CELL-LINE; PRIMARY HEPATOCYTES;

CELL CULTURE;

ANIMAL CELL; ARTIFICIAL LIVER; CONFERENCE PAPER; DETOXIFICATION; HUMAN; LIVER CELL; LIVER FAILURE; NONHUMAN;

EID: 0029912377     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889601900104     Document Type: Conference Paper

References (25)

1. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes. Regulation of acute phase protein synthesis by interteukin-6. Hepatology 1990; 12: 1179-86.
2. Hammer C. Transgenic pigs as potential organ donors. Diatra Journal 1994; 4: 29-32.
3. Michalopulos G. HGF and liver regeneration. Gastroenterol Jpn 1993; 28: 36-9.
4. Michalopulos G, Houck KA, Dolan ML, Luetteke NC. Control of hepatocyte replication by two serum factors. Cancer Research 1984; 44: 4414-9.
5. Michalopulos G, Pitot HC. Primary culture of parenchymal liver cells on collagen membranes. Experimental Cell Research 1975; 94: 70-8.
6. Gislason G, Lobdell D, Kelly J, Sussmann N. A treatment system for implementing an extracorporeal liver assist device. Artif Organs 1994; 18: 385-9.
7. Sussman N, Kelly J. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 1993; 17: 27-9.
8. Javitt N. HepG2 cells as a resource for metabolic studies; lipoprotein, cholesterol, and bile acids. FASEB J 1990; 4: 161-8.
9. Stevenson D, Lin H, Tong M, Marshall G. Characteristics of a cell line (TONG/HCC) established from a human hepatocellular carcinoma. Hepatology 1987; 7: 1291-5.
10. Strauss M, Hering S, Lieber A, Herrmann G, Griffin BE, Arnold W. Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis. Oncogene, (in press) 1995.
11. Schuetz EG, Schuetz JD, Strom SC, et al. Regulation of human liver cytochromes p-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 1993; 18: 1254-62.
12. Stange J, Mitzner S, Strauss M, et al. Comparison of encapsulated primary isolated and established hepatocytes for their applicability as liver replacement. Artif Organs 1993; 17: 488.
13. Muller TE, Jaurequi HO. Letter to the editor. Artif Organs 1993; 17: 44-5.
14. Sussman N, Kelly J. Letter to the editor. Artif Organs 1993; 17: 43-4.
15. Hering S, Griffin BE, Strauss M. Immortalization of human fetal sinusoidal liver cells by polyoma virus large T antigen. Experimental Cell Research 1991; 195: 1-7.
16. Gerlach J, Brombacher J, Kloppel K, Schnoy N, Neuhaus P. Comparison of four methods for mass hepatocyte isolation from pig and human livers. Transplantation 1994; 57: 1318-22
17. Jauregui HO, Gann KL. Mammalian hepatocytes as a foundation for treatment in human liver failure. Journal of Cellular Biochemistry 1991; 45: 359-65.
18. Jauregui HO, Naik S, Driscoll JL, Solomon BA, Galetti PM. Adult rat hepatocyte cultures as the cellular component of an artificial hybrid liver. In: Paul JP, Gaylor JDS, Courtney JM, Gilchrist T, eds. Strathclyde Bioengineering Seminars: Biomaterials in Artificial Organs. Macmillan, 1983; 130-9.
19. Matsumura KN, Guevara GR, Hutson H, et al. Hybrid bioartificial liver in hepatic failure. Preliminary clinical report. Surgery 1987; 101: 99-103.
20. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO Journal 1993; 39: 621-5.
21. Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin bound toxins. Artif Organs 1993; 17: 809-13.
22. Buchner NL. Liver regeneration: an overview. Journal of Gastroenterology and Hepatology 1991; 6: 615-24.
23. Emerson TEJ, Fournel MA, Leach WJ, Redens TB. Protection against disseminated intravascular coagulaton and death by antithrombin-III in the escherichia coli endotoxemic rat. Circulatory Shock 1987; 21: 1-13
24. 1-proteinase inhibitor in the E. coli endotoxemic sheep pulmonary dysfunction model. Circulatory Shock 1988; 26: 15-26.
25. Sussman N, Kelly J. Letter to the editor. Artif Organs 1993; 17: 43-4.